Related Experiment Video

Updated: Dec 3, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.5K

Frequently Asked Questions about Thrombosis during COVID-19 Pandemic

Lolita Golemi1, Peter Hanson2, Alfonso Tafur3

  • 1Rush Medical College, Chicago, Illinois, United States.

TH Open : Companion Journal to Thrombosis and Haemostasis
|October 26, 2020
PubMed

Insights

The COVID-19 pandemic caused significant strain. Patient education is vital for informed health decisions, especially regarding growing thrombosis concerns during shelter-in-place orders.

Area of Science:

  • Medicine
  • Public Health
  • Hematology

Background:

  • The COVID-19 pandemic and associated shelter-in-place orders have created unprecedented challenges for patients and healthcare providers.
  • Maintaining patient engagement and informed decision-making is difficult under these stressful conditions.
  • A specific concern emerging is the increased risk of thrombosis (blood clots) in patients during this period.

Purpose of the Study:

  • To address the growing concern of thrombosis during the COVID-19 pandemic.
  • To provide patient-centered education on thrombosis risks and management.
  • To empower patients and healthcare providers with knowledge for optimal health decisions.

Main Methods:

  • A review of frequently asked questions (FAQs) related to thrombosis.
  • Information synthesized from a patient-perspective.
  • Focus on practical guidance for patients and providers.

Main Results:

  • Identified key patient questions regarding thrombosis during the pandemic.
  • Highlighted the importance of proactive patient education.
  • Illustrated the link between pandemic conditions and increased thrombosis risk.

Conclusions:

  • Patient education is a critical component of healthcare delivery during pandemics.
  • Addressing thrombosis concerns requires a collaborative approach between patients and providers.
  • Empowering patients with information facilitates better health outcomes amidst public health crises.

Keywords:
COVID-19anticoagulantsdeep vein thrombosispulmonary embolism

More Related Videos

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots06:12

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Published on: July 21, 2023

869
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

3.0K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
158
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
146
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
159
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
124
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.7K